Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 11, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Steven Seedhouse Maintained (APLS) at Strong Buy with Increased Target to $106 on, Jan 11th, 2024
Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $67 to $106 on, Jan 11th, 2024.
Steven has made no other calls on APLS in the last 4 months.
There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 3 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $54 on, Thursday, December 14th, 2023
- Graig Suvannavejh of "Mizuho" Initiated at Hold and Held Target at $42 on, Thursday, November 2nd, 2023
- Brian Cheng of "B of A Securities" Maintained at Hold with Increased Target to $46 on, Thursday, October 12th, 2023
These are the ratings of the 7 analyists that currently disagree with Steven
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
- Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $75 on, Friday, December 15th, 2023
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $67 on, Friday, December 15th, 2023
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $56 on, Thursday, December 14th, 2023
- Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $85 on, Tuesday, December 5th, 2023
- Anupam Rama of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $81 on, Friday, October 6th, 2023
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $82 on, Tuesday, September 26th, 2023
